Sanofi
- Country
- 🇫🇷France
- Ownership
- Public
- Employees
- 87.9K
- Market Cap
- $141.3B
- Website
- http://www.sanofi.com
- Introduction
Sanofi engages in the research, production, and distribution of pharmaceutical products. It operates through the following business segments: Pharmaceuticals, Consumer Healthcare, and Vaccines. The Pharmaceuticals segment comprises the commercial operations of the following global franchises: specialty care, diabetes and cardiovascular, established prescript...
PERSPECTIVE: Telithromycin - Acute Exacerbation of Chronic Bronchitis
- Conditions
- First Posted Date
- 2005-08-22
- Last Posted Date
- 2011-06-08
- Lead Sponsor
- Sanofi
- Target Recruit Count
- 5660
- Registration Number
- NCT00132938
- Locations
- 🇹🇷
Sanofi-Aventis, Istanbul, Turkey
OPTAMISE: Clinical Effectiveness of Teriparatide After Alendronate or Risedronate Therapy in Osteoporotic Postmenopausal Women
- Conditions
- First Posted Date
- 2005-08-15
- Last Posted Date
- 2011-01-11
- Lead Sponsor
- Sanofi
- Target Recruit Count
- 290
- Registration Number
- NCT00130403
- Locations
- 🇦🇺
sanofi-aventis, Australia, Cove, New South Wales, Australia
🇨🇦sanofi-aventis, Canada, Laval, Quebec, Canada
🇧🇪sanofi-aventis, Belgium, Diegem, Belgium
TREAD-20: Trial of Hyalgan Three Injection-Regimen for the Treatment of Knee Pain Due to Osteoarthritis
- Conditions
- First Posted Date
- 2005-08-15
- Last Posted Date
- 2008-04-03
- Lead Sponsor
- Sanofi
- Target Recruit Count
- 150
- Registration Number
- NCT00130468
- Locations
- 🇺🇸
Sanofi-Aventis Inc, Bridgewater, New Jersey, United States
CONCEPT: Comparison of Oxaliplatin vs Conventional Methods With Calcium/Magnesium in First-Line Metastatic Colorectal Cancer
- Conditions
- First Posted Date
- 2005-08-12
- Last Posted Date
- 2009-02-13
- Lead Sponsor
- Sanofi
- Target Recruit Count
- 180
- Registration Number
- NCT00129870
- Locations
- 🇺🇸
Sanofi-Aventis, Bridgewater, New Jersey, United States
Safety, Tolerability, and Immunogenicity Study of a Clostridium Difficile Toxoid Vaccine in Healthy Adult Volunteers
- Conditions
- Interventions
- First Posted Date
- 2005-08-09
- Last Posted Date
- 2012-09-14
- Lead Sponsor
- Sanofi
- Target Recruit Count
- 50
- Registration Number
- NCT00127803
SOLMANIA - Comparison of Valproate-Amisulpride and Valproate-Haloperidol in Bipolar I Patients
- Conditions
- First Posted Date
- 2005-08-02
- Last Posted Date
- 2008-04-10
- Lead Sponsor
- Sanofi
- Target Recruit Count
- 120
- Registration Number
- NCT00126009
- Locations
- 🇪🇸
Sanofi-Aventis, Barcelona, Spain
STRADIVARIUS (Strategy To Reduce Atherosclerosis Development InVolving Administration of Rimonabant - the Intravascular Ultrasound Study)
- Conditions
- First Posted Date
- 2005-07-27
- Last Posted Date
- 2009-04-20
- Lead Sponsor
- Sanofi
- Target Recruit Count
- 839
- Registration Number
- NCT00124332
- Locations
- 🇧🇪
sanofi-aventis, Belgium, Diegem, Belgium
🇵🇱sanofi-aventis Poland, Warszawa, Poland
🇨🇦Sanofi-Aventis Administrative Office, Laval, Canada
Hexadecasaccharide (SR123781A) in Patients With Unstable Angina or Non-ST-Segment Elevation Myocardial Infarction
- Conditions
- First Posted Date
- 2005-07-25
- Last Posted Date
- 2008-08-21
- Lead Sponsor
- Sanofi
- Target Recruit Count
- 1257
- Registration Number
- NCT00123565
- Locations
- 🇹🇷
Sanofi-Aventis, Istanbul, Turkey
🇫🇷Sanofi-Aventis France, Paris, France
🇪🇸Sanofi-aventis, Barcelona, Spain
Comparison of the Ability of Glulisine With Lispro to Control Type 1 Diabetes Mellitus in Children and Adolescents
- Conditions
- Interventions
- First Posted Date
- 2005-06-24
- Last Posted Date
- 2016-05-20
- Lead Sponsor
- Sanofi
- Target Recruit Count
- 572
- Registration Number
- NCT00115570
- Locations
- 🇺🇸
Childrens Hospital of Pittsburgh, Pittsburgh, Pennsylvania, United States
Platelet Aggregation Inhibition in Children on Clopidogrel (PICOLO)
- Conditions
- First Posted Date
- 2005-06-22
- Last Posted Date
- 2009-03-25
- Lead Sponsor
- Sanofi
- Target Recruit Count
- 92
- Registration Number
- NCT00115375
- Locations
- 🇮🇹
Sanofi-Aventis Administrative Office, Milano, Italy